This is a PAID ADVERTISEMENT provided to customers of Schaeffer's Investment Research. Although we have sent you this email, Schaeffer's not specifically endorse this product nor is it responsible for the content of this advertisement. Furthermore, we make no guarantee or warranty about what is advertised above. Your privacy is very important to us, if you wish to be excluded from future notices, do not reply to this message. Instead, please go to the following address: http://www.schaeffersresearch.com/schaeffers-unsubscribe-partner?email=indra21poetra@gmail.com DISCLAIMER: In accordance with Section 17(b) of the Securities Act of 1933, you are hereby advised that Schaeffer’s Investment Research, Inc. "Schaeffer’s" is receiving a fee of over $1000.00 in cash, from an independent third party as compensation for the distribution of this advertisement. Schaeffer’s has not determined if the statements and opinions of the advertiser are accurate, correct or truthful. The purpose of this advertisement, like any advertising, is to provide publicity for the advertising company, its products or services. You should not rely on the information presented; you should do independent research to form your own opinion and decision. Information contained in our disseminated emails does not constitute investment, legal or tax advice upon which you should rely. The purchase of high-risk securities may result in the loss of your entire investment. |
Kamis, 26 Juli 2018
A Biotech With Plays In The Pharmaceutical Industry As Well!
BioPharmaceuticals and biologics are the future of medicine and long-term growth, but pharmaceuticals are the profits that pave the way.
Wall Street darlings like Johnson & Johnson, Pfizer, and Roche have continued to prove the upward viability of biotech and pharmaceutical companies.
This particular biopharmaceutical company is targeting the future of stem cell biologics, along with the profitability of the pharmaceutical compounding and reformulation industry. This means HUGE upside potential, all while continuing to sustain profitability via pharmaceutical sales.
See why this could be the
(Get The Details On This BioPharma Company)
Tidak ada komentar:
Posting Komentar